Cellectis S.A.

Cellectis S.A.verified

CLLS

Price:

$3.09

Market Cap:

$231.33M

Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express chimeric antigen receptors, designed to specifically identify and eliminate malignant cells. Its operations are divided into two distinct divisions: Therapeutics and Plants. The therapeutic pipeline includes several product candidates currently undergoing development. Among these is UCART19, an allogeneic T-cell therapy targeting CD19-expressing blood cancers such as acute lymphoblastic leukemia. Other key developments encompass ALLO-501 and ALLO-501A, designed for diffuse large B-cell lymphoma ...[Read more]

Industry

Biotechnology

IPO Date

2015-03-24

Stock Exchange

NASDAQ

Ticker

CLLS

The ROE as of June 2026 (TTM) for Cellectis S.A. (CLLS) is -80.61%

According to Cellectis S.A.’s latest financial reports and current stock price. The company's current ROE is -80.61%. This represents a change of 266.25% compared to the average of -22.01% of the last 4 quarters.

Cellectis S.A. (CLLS) Historical ROE (quarterly & annually)

How has CLLS ROE performed in the past?

The mean historical ROE of Cellectis S.A. over the last ten years is -49.78%. The current -80.61% ROE has changed 61.95% with respect to the historical average. Over the past ten years (40 quarters), CLLS's ROE was at its highest in in the March 2024 quarter at 6.23%. The ROE was at its lowest in in the December 2023 quarter at -50.61%.

Quarterly (TTM)
Annual

Average

-49.78%

Median

-33.01%

Minimum

-119.32%

Maximum

-19.23%

Cellectis S.A. (CLLS) ROE by Quarter and Year

Discovering the peaks and valleys of Cellectis S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 230.33%

Maximum Annual ROE = -19.23%

Minimum Annual Increase = -76.49%

Minimum Annual ROE = -119.32%

Quarterly (TTM)
Annual
YearROEChange
2025-92.67%230.33%
2024-28.05%-76.49%
2023-119.32%42.63%
2022-83.66%114.56%
2021-38.99%48.05%
2020-26.33%-8.49%
2019-28.78%49.68%
2018-19.23%-48.38%
2017-37.25%58.60%
2016-23.48%200.52%

Cellectis S.A. (CLLS) Average ROE

How has CLLS ROE performed in the past?

The current ROE of Cellectis S.A. (CLLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-80.02%

5-year avg

-72.54%

10-year avg

-49.78%

Cellectis S.A. (CLLS) ROE vs. Peers

How is CLLS’s ROE compared to its peers?

Cellectis S.A.’s ROE is greater than Alto Neuroscience, Inc. (-47.22%), greater than AC Immune S.A. (-123.98%), greater than Aldeyra Therapeutics, Inc. (-57.34%), greater than Amarin Corporation plc (-7.34%), greater than Alpha Tau Medical Ltd. (-73.23%), greater than Larimar Therapeutics, Inc. (-134.14%), greater than Silence Therapeutics plc (-121.71%), greater than DBV Technologies S.A. (-130.06%), greater than Mereo BioPharma Group plc (-81.25%), greater than Korro Bio, Inc. (-117.86%),

Build a custom stock screener for Cellectis S.A. (CLLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectis S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectis S.A. (CLLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Cellectis S.A.'s ROE?

How is the ROE calculated for Cellectis S.A. (CLLS)?

What is the highest ROE for Cellectis S.A. (CLLS)?

What is the 3-year average ROE for Cellectis S.A. (CLLS)?

What is the 5-year average ROE for Cellectis S.A. (CLLS)?

How does the current ROE for Cellectis S.A. (CLLS) compare to its historical average?